Category and country
CDMO companies in Finland
6 cdmo profiles in Finland. Every profile is hand-reviewed with leadership, certifications, and public sources.
Where does cdmo cluster in Finland?
Kuopio (2), Oulu (2), Helsinki (1), and Turku (1) Most visible profiles: Kuopio Center for Gene and Cell Therapy, Pharmatory, Paras Biopharmaceuticals Finland, and FinVector.
Which standards are already visible?
GMP (5) and FDA-Inspected (2) Latest review: 24 April 2026. Review cycle: April 2026.
Full list
CDMO profiles in Finland
6 profiles match the active filter.
Current review cycle
Kuopio Center for Gene and Cell Therapy
KuopioFinlandCDMO
Kuopio ATMP CDMO providing Fimea-authorized GMP viral-vector manufacturing (AAV, adenovirus, lentivirus) for gene and cell therapy programs, owned by Ferring Ventures since 2020.
- Lead
- Tuija KekarainenScientific Director and Cell Therapy Unit Director
- Scale
- GMP viral-vector manufacturing
Current review cycle
Pharmatory
OuluFinlandCDMO
Oulu API CDMO providing process R&D, analytical services, and cGMP contract manufacturing for human and veterinary pharmaceutical clients.
- Lead
- Jaana KarjalainenCEO and Managing Director
- Scale
- Commercial and development-stage API platform
Current review cycle
Paras Biopharmaceuticals Finland
OuluFinlandCDMO
Oulu biopharmaceutical company focused on biosimilars, recombinant biologics, and process technologies from a Finnish operating base.
- Lead
- Ashesh KumarFounder and Director
- Scale
- Development-stage biologics platform
Current review cycle
FinVector
KuopioFinlandCDMO
Kuopio gene-therapy CDMO and viral-products manufacturer operating cGMP production, drug-substance and drug-product suites, and a growing pharma campus in Savilahti.
- Lead
- Matthias KriegerManaging Director
- Scale
- Clinical-to-commercial gene-therapy manufacturing
Current review cycle
3PBIOVIAN
TurkuFinlandCDMO
Turku biologics and viral-vector CDMO site offering microbial proteins, plasmid DNA, viral vectors, aseptic fill-finish, and QC services under EMA-certified and FDA-inspected GMP operations.
- Lead
- Damaso MoleroChief Executive Officer
- Scale
- Investigational to commercial GMP manufacturing
Current review cycle
Nanoform Finland
HelsinkiFinlandCDMO
Helsinki particle-engineering CDMO using proprietary nanoforming technology to improve drug solubility and move small-molecule programs from development into clinical and commercial supply.
- Lead
- Edward HaeggstromChief Executive Officer
- Scale
- Clinical to Commercial
Related brief
Read deeper on this category
European CDMO Capacity 2026: Biologics, Fill-Finish, Small Molecule
Where to look for biologics, fill-finish, small-molecule, and specialised CDMO capacity across Europe in 2026 — 33 CDMOs in the directory across 9 countries, organised by what they actually do and where they sit.
Open briefFAQ
Frequently asked questions on this category
- What is a CDMO?
- A Contract Development and Manufacturing Organization handles drug development and production for other pharma or biotech companies. The work spans process development, scale-up, GMP manufacturing, fill-finish, packaging, and analytical testing.
- Which European countries have the most CDMO capacity?
- Switzerland and Germany lead by depth and quality (Basel, Heidelberg, Mainz). Poland adds large-scale manufacturing capacity, Lithuania has a growing biologics CDMO presence anchored in Vilnius, and the Nordics carry strong fill-finish and aseptic operators in Denmark and Sweden.
- How are these CDMO companies verified?
- Every profile is hand-reviewed against an audit framework: leadership identity confirmed by primary source, physical site address sourced from official disclosures, regulatory matrix (GMP / ISO-13485 / GLP / FDA-Inspected) backed by certification documents, and a registry note explaining the company's current operating context.
- Can I compare two CDMO providers side by side?
- Yes — use the Compare button on any company card to add it to a comparison set (up to 3 companies), then open the /compare page for a side-by-side view of leadership, certifications, and operating scale.
Next step
Compare companies or open the wider market.
Use the compare tool to view two or three companies side by side, or open the country hub for the full market view.